Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Percutaneous Electrical Nerve Field Stimulation for Irritable Bowel Syndrome | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Pelvic Floor Stimulation as a Treatment of Urinary and Fecal Incontinence | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Pediatric Dental Anesthesia | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | PCSK9 Inhibitors | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Patient-Specific Instrumentation (eg, Cutting Guides) for Joint Arthroplasty | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Patient-Controlled End Range of Motion Stretching Devices | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Pathogen Panel Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Parenteral (PEN) and Enteral (EN) Nutrition Support in the Home | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Parathyroid Autotransplantation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Paraspinal Surface Electromyography to Evaluate and Monitor Back Pain | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Papzimeos (zopapogene imadenovec-drba) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Palynziq (pegvaliase-pqpz) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Pain Control Infusion Pump | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oxygen | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oxlumo (lumasiran) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ovarian and Internal Iliac Vein Endovascular Occlusion as a Treatment of Pelvic Congestion Syndrome | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Otoplasty, Unilateral or Bilateral | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Otezla (apremilast) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Orthoptic Training for the Treatment of Vision or Learning Disabilities | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Orthopedic Applications of Stem Cell Therapy (Including Allografts and Bone Substitutes Used with Autologous Bone Marrow) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Orthopedic Applications of Platelet-Rich Plasma | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Orthognathic Surgery (Overbite/Underbite) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Organic Acid Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oral Oncology | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oracea (doxycycline, biphasic release) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Optical Coherence Tomography of the Anterior Eye Segment | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Optical Coherence Tomography for Imaging of Coronary Arteries | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Opioid Antagonists under Heavy Sedation or General Anesthesia as a Technique of Opioid Detoxification | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Opioid and Opioid Combination Medications | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ophthalmologic Techniques That Evaluate the Posterior Eye Segment for Glaucoma | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ophthalmic Anti-Inflammatory Medications | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oncologic Applications of Positron Emission Tomography (PET) Scanning | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Oncologic Applications of Photodynamic Therapy, Including Barrett Esophagus | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ocriplasmin for Symptomatic Vitreomacular Adhesion | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Occlusion of Uterine Arteries Using Transcatheter Embolization | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Occipital Nerve Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nuzyra (omadacycline) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nutrient/Nutritional Panel Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nuplazid (pimavanserin) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nuedexta (dextromethorphan and quinidine) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | NSAIDs | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Noxafil/Vfend | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Noritate 1% (metronidazole cream) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nonmyeloablative Allogeneic Transplants of Hematopoietic Stem-Cells for Treatment of Malignancy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Noninvasive Prenatal Screening for Fetal Aneuploidies, Microdeletions, Single-Gene Disorders, and Twin Zygosity Using Cell-Free Fetal DNA | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNA | New policy |